SurvivorNet
The trusted source for cancer information.
| Date | Investors | Amount | Round |
|---|---|---|---|
$10.0m | Series B | ||
| Total Funding | 000k | ||
| USD | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 50 % | - | 5 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
SurvivorNet, founded in 2018 by former ABC News producer Steve Alperin and venture capitalist Tim Langloss, is a New York-based media company focused on providing cancer information. The company was born out of Alperin's personal experience with his father's cancer diagnosis, which highlighted the need for accessible and reliable information for patients and their families.
SurvivorNet operates as a B2C platform, offering a range of video-based educational resources that bring together insights from experts at leading comprehensive cancer centers. The platform aims to democratize access to cancer information, empowering patients to make more informed decisions about their treatment and care. The company's business model is centered around its content platform, which reaches millions of people each month. SurvivorNet has successfully raised $15 million in a Series B funding round to support its growth and expand its reach.
Keywords: cancer information, patient education, health media, video resources, oncology, patient empowerment, digital health, medical information, healthcare content, cancer support